Stocks and Investing
Stocks and Investing
Mon, August 12, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Whitney Ijem Maintained (VERV) at Strong Buy with Decreased Target to $29 on, Aug 12th, 2024
Whitney Ijem of Canaccord Genuity, Maintained "Verve Therapeutics, Inc." (VERV) at Strong Buy with Decreased Target from $30 to $29 on, Aug 12th, 2024.
Whitney has made no other calls on VERV in the last 4 months.
There is 1 other peer that has a rating on VERV. Out of the 1 peers that are also analyzing VERV, 0 agree with Whitney's Rating of Hold.
This is the rating of the analyst that currently disagrees with Whitney
- Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $20 on, Friday, August 9th, 2024
Contributing Sources